Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01757626
Brief Title: Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

First Submitted : December 21, 2012
First Submitted that Met QC Criteria : December 21, 2012
First Posted : December 31, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : April 30, 2020
Last Update Posted : May 1, 2020